InsiderClue
Insiders · Profile

PRASAD SUYASH

CMO and Head of R&D at Taysha Gene Therapies. Filing since 29 Jun 2021. CIK 0001679129

Company
Date
Role
Action
Shares
Amount
Of holding
TSHA Taysha Gene Therapies, Inc.
6 Jul 2022
CMO and Head of R&D
Sold, plan not stated
8,956
$33.94K
1.7%
TSHA Taysha Gene Therapies, Inc.
5 Jul 2022
CMO and Head of R&D
Sold, plan not stated
3,905
$13.71K
0.7%
TSHA Taysha Gene Therapies, Inc.
1 Jul 2022
CMO and Head of R&D
Sold, plan not stated
23,923
$84.45K
4.2%
TSHA Taysha Gene Therapies, Inc.
30 Jun 2022
CMO and Head of R&D
Sold, plan not stated
13,892
$51.68K
2.4%
TSHA Taysha Gene Therapies, Inc.
29 Jun 2022
CMO and Head of R&D
Sold, plan not stated
12,324
$46.95K
2.1%
TSHA Taysha Gene Therapies, Inc.
1 Jul 2021
CMO and Head of R&D
Sold, plan not stated
19,706
$416.19K
3.2%
TSHA Taysha Gene Therapies, Inc.
30 Jun 2021
CMO and Head of R&D
Sold, plan not stated
20,076
$437.49K
3.2%
TSHA Taysha Gene Therapies, Inc.
29 Jun 2021
CMO and Head of R&D
Sold, plan not stated
39,218
$934.25K
5.8%
8 decisions on file.